Eugene, ORNCT05691439Now EnrollingIRB Ready

Depression in Adolescence Clinical Trial in Eugene, OR

Access cutting-edge depression in adolescence treatment through this clinical trial at a research site in Eugene. Study-provided care at no cost to qualified participants.

Sponsored by University of Oregon

Quick Self-Assessment

See if you qualify for this Eugene location

Preparing your pre-screening questions…

Expert Care in Eugene

Access depression in adolescence specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related depression in adolescence treatment provided free

Apply for This Eugene Location

Check if you qualify for this depression in adolescence clinical trial in Eugene, OR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Eugene

    Convenient for OR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Eugene site if eligible
  4. 4Begin participation

About This Depression in Adolescence Study in Eugene

This research will use biobehavioral approaches to generate understanding about the linkages between sleep duration and timing, stressful life events, and depressive symptoms in adolescents, with a long-term aim of developing effective preventative interventions.

Sponsor: University of Oregon

Who Can Participate

Inclusion Criteria

14-18 years of age
Currently in high school
short and late sleep (weekday sleep duration ≤ 7 h and bedtime ≥ 22:30 (10:30 pm); n=100) or long and early sleep (weekday sleep duration \> 7 hours and bedtime ≤ 22:30 (10:30 pm); n=50), indexed by the Munich Chronotype Questionnaire
Lifetime stressful event frequency ≥ 2 on the Stress and Adversity Inventory (STRAIN) Screener
Depressive symptom severity t-score greater than or equal to 45 on the Patient Reported Outcomes (PROMIS) Depression scale
English language fluency

Exclusion Criteria

Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for current moderate to severe alcohol/substance use disorder (≥4 symptoms);
Current clinician-provided diagnosis of narcolepsy or idiopathic hypersomnia;
Lifetime diagnosis of bipolar or schizophrenia spectrum disorder;
Certain medical conditions (e.g., serious neurological disorder, heart failure or serious heart trouble, history of head injury with unconsciousness \> 5 minutes);
Conditions that are contraindicated for magnetic resonance imaging (MRI; e.g., ferrous metal in the body);
Positive screen for participant-reported eye disease, epilepsy, or photosensitizing medications that are contraindicated during the manipulation condition when bright light is administered (e.g., psychiatric neuroleptic drugs \[e.g., phenothiazine\], psoralen drugs, antiarrhythmic drugs \[e.g., amiodarone\], antimalarial and antirheumatic drugs, porphyrin drugs used in photodynamic treatment of skin diseases);
Use of melatonin if participant is not willing to discontinue use for the duration of the study. We will schedule around (i.e., delay appointments as needed) to avoid the timeframe of the following events:
urgent suicide risk, defined by moderate/severe risk per Columbia Suicide Severity Rating Scale (CSSRS) and clinician determination that current risk requires immediate action;
travel across two or more time zones within the month prior to the overnight study visits;
beginning or ending a prescribed medication within 2 months of the observational study;
prescribed medication dose changes within the timeframe calculated as 5x the drug's half-life \[the time to reach pharmacokinetic steady-state\] before the initiation of the observational or experimental studies;
anticipated change in prescribed medications or medication dosing during the observational or experimental studies;
current symptoms of airborne infectious illness prior to laboratory visits. Participants with positive breathalyzer screen (blood alcohol level \> .02) will be rescheduled for an alternative overnight visit date.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Eugene?

Yes, this clinical trial (NCT05691439) has an active research site in Eugene, OR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Depression in Adolescence Treatment Options in Eugene, OR

If you're searching for depression in adolescence treatment options in Eugene, OR, this clinical trial (NCT05691439) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Eugene research site is actively enrolling participants for this clinical trial. You'll receive care from experienced depression in adolescence specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all depression in adolescence clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Eugene, OR

See all alzheimers disease clinical trials recruiting in Eugene — not just this study.

Browse Alzheimers Disease Trials in Eugene →

Browse More Trials by Condition

Alzheimers Disease TrialsDepression TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Eugene?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Eugene, OR